Topics

Ibrutinib Therapy Linked to New, Worsened Hypertension

08:00 EDT 11 Oct 2019 | Drugs.com

FRIDAY, Oct. 11, 2019 -- Ibrutinib is associated with an increased risk for new or worsened hypertension in patients treated for B-cell malignancies, according to a study published online Oct. 3 in Blood. Tyler Dickerson, Ph.D., from The Ohio State...

Original Article: Ibrutinib Therapy Linked to New, Worsened Hypertension

NEXT ARTICLE

More From BioPortfolio on "Ibrutinib Therapy Linked to New, Worsened Hypertension"

Quick Search

Relevant Topic

Pulmonary Hypertension
Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs of affected individuals. Symptoms can range from mild breathles...